Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_research_and_manufacturers_of_america [2022/07/20 20:29]
pamela
+++ pharmaceutical_research_and_manufacturers_of_america [2022/09/15 00:21] (current)
liam
@@ Line 4: / Line 4: @@
 **Pharmaceutical Research and Manufacturers of America (PhRMA)** is an American trade association based in [[united_states_of_america:Washington, DC]] that lobbies on behalf of [[pharmaceutical companies]]. PhRMA has offices in [[Japan]] and the [[United Arab Emirates]].((//About.// (2018, September 26). Wayback Machine; PhRMA. https://web.archive.org/web/20180926013616/https://www.phrma.org/about))
+It raises funds through the [[PhRMA Foundation]].
 ===== History =====
@@ Line 12: / Line 14: @@
 Member companies include [[pharmaceutical_companies:AbbVie]], [[pharmaceutical_companies:Alkermes]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Biogen]], [[pharmaceutical_companies:BioMarin]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[pharmaceutical_companies:CSL Behring]], [[pharmaceutical_companies:Daiichi-Sankyo]], [[pharmaceutical_companies:Eisai]], [[pharmaceutical_companies:Eli Lilly]], [[pharmaceutical_companies:EMD Serono]], [[pharmaceutical_companies:Genentech]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Incyte]], [[pharmaceutical_companies:Ipsen Biopharmaceuticals]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Lundbeck]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novo Nordisk]], [[pharmaceutical_companies:Otsuka]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Sage Therapeutics]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Sunovion]], [[pharmaceutical_companies:Takeda]], [[pharmaceutical_companies:Teva]], and [[pharmaceutical_companies:UCB]].((//About.// PhRMA. Retrieved April 5, 2022, from https://www.phrma.org/about))
+===== PhARMA Lobbying Impact =====
@@ Line 34: / Line 38: @@
 Dr. Marcia Angell, a senior lecturer at Harvard Medical School, is a guest columnist.((https://web.archive.org/web/20070325114624/http://www.boston.com/news/globe/editorial_opinion/oped/articles/2007/02/26/taking_back_the_fda/))
+==== Bioshield Two ====
+Biodefense and Pandemic Vaccine and Drug Development Act of 2005 (S. 1873), nicknamed "Bioshield Two" and sponsored by Senator [[:Richard Burr]] (R-North Carolina), aims to shortcut safety testing for new vaccines and drugs in case of a pandemic, and to protect vaccine makers and the pharmaceutical industry from legal liability for vaccine injuries. Co-sponsored by [[:Bill Frist]] (R-TN), [[:Mike Enzi]] (R-WY), and [[:Judd Gregg]] (R-NH), by voice vote, despite Democratic objections.
+How many lawyers and lobbyists does it take to define pandemic as anything at all to anyone on the public dime and an assigned parking space near the door? In 2005 Bill Moyers reported 35 lobbyists per Member of Congress. Just counting sponsors 4x35= 140 lobbyists potentially helping. That's PhARMA teamwork!
+=== Senate Bill ===
+Oct 17, 2005 · Biodefense and Pandemic [[:Vaccine]] and Drug Development Act of 2005 - (Sec. 3) Amends the Public Health Service Act to establish the [[:Biomedical Advanced Research and Development Agency]] (BARDA) within the Department of [[:Health and Human Services]] (HHS) to coordinate and oversee activities that support and accelerate advanced research and development of qualified countermeasures to exposure to hazardous agents or infectious diseases or qualified pandemic or epidemic products.
+Establishment.--There is established within
+        the Department of Health and Human Services, the Biomedical
+        Advanced Research and Development Agency.</DELETED>
+        <DELETED>    ``(2) Purpose.--It shall be the purpose of the
+        BARDA to coordinate and oversee activities that support and
+        accelerate qualified countermeasure or qualified pandemic or
+        epidemic product (referred to in this section as
+        `countermeasure or product') advanced research and development
+        by--</DELETED>
+        (8) Person.--The term `person' includes an
+        individual, partnership, corporation, association, entity, or
+        public or private corporation, including a Federal, State, or
+        local agency or department.
+        SEC. 319L. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT
+              AGENCY.</DELETED>
+<DELETED>    ``(a) Definitions.--In this section:</DELETED>
+        <DELETED>    ``(1) BARDA.--The term `BARDA' means the
+        Biomedical Advanced Research and Development Agency.</DELETED>
+        <DELETED>    ``(2) Fund.--The term `Fund' means the Biodefense
+        Medical Countermeasure Development Fund established under
+        subsection (d).</DELETED>
+        <DELETED>    ``(3) Other transactions.--The term `other
+        transactions' means transactions, other than procurement
+        contracts, grants, and cooperative agreements, including
+        transactions for prototypes, as provided to the Secretary of
+        Defense under section 2371 of title 10, United States
+        Code. ((https://web.archive.org/web/20160402133240/https://www.congress.gov/bill/109th-congress/senate-bill/1873/text))